On CNBC's "Mad Money Lightning Round," Jim Cramer said that Archer Daniels Midland Co (NYSE: ADM) is a chronic underperformer. Those who like it for yield, should buy Verizon Communications Inc. (NYSE
InMode (NASDAQ:INMD) and CONMED (NASDAQ:CNMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitabilit
AxoGen (NASDAQ:AXGN) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutiona

12 Short Squeeze Candidates To Watch

06:07pm, Friday, 17'th Apr 2020
One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a l
Zacks.com featured highlights include: DHT, Blucora, InMode and Enphase Energy

4 Stocks With High Net Income Ratio to Scoop Up

03:22pm, Wednesday, 08'th Apr 2020
Profitability analysis is one of the best ways to evaluate the prospects of a company.

4 Stocks With High Net Income Ratio to Scoop Up

01:42pm, Wednesday, 08'th Apr 2020
Profitability analysis is one of the best ways to evaluate the prospects of a company.
InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its results for the first quarter 2020 before the Nasdaq market ope
The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group

5 Stocks to Buy for 5 Good Reasons

08:33pm, Friday, 03'rd Apr 2020
Here are 5 ways to make the most of a difficult market.
Given the current economic slowdown, we have shortlisted six defensive stocks that can return well on investment.
The current economic slowdown led by rise in coronavirus cases calls for investing in defensive stocks.

InMode (INMD) Gets a Buy Rating from Barclays

05:44pm, Thursday, 26'th Mar 2020
Barclays analyst Jack Meehan maintained a Buy rating on InMode ( INMD – Research Report ) today and set a price target of $36.00 . The company’s shares closed last Monday at $23.80. According to T

InMode Provides COVID-19 Business Update

12:47pm, Monday, 23'rd Mar 2020
InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today provided an update regarding its business activities in light of the ongoing global health si
During the Mad Money program host Jim Cramer makes time for callers to ask about securities they are interested in. InMode makes a skin rejuvenation device I could use about now, but let's look at th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE